GET HELP NOW

Wednesday, October 25, 2017

Researchers engineer complex TCR immunotherapy that may target relapsing leukemia

http://ift.tt/eA8V8J Researchers have developed a novel way to genetically engineer T cells that may be effective for treating and preventing leukemia relapse. The findings provide the basis for launching a first-in-human clinical trial of this new immunotherapy, which relies on engineered T-cell receptors, or TCRs.

from http://ift.tt/2y7hzTM
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Children whose mothers use marijuana are more likely to try it at younger age

When mothers use marijuana during the first 12 years of their child's life, their cannabis-using children are more likely to start at an...